suggested 17 % decrease in deaths (OS) but the degree if certainty is unassessable
suggested 69 % decrease in AE (any grade) but the degree if certainty is unassessable
suggested 64 % decrease in AE leading to treatment discontinuation (any grade) but the degree if certainty is unassessable
suggested 95 % decrease in TRAE (any grade) but the degree if certainty is unassessable
suggested 91 % decrease in TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 96 % decrease in Anaemia TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 98 % decrease in Blood and lymphatic system disorders TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 88 % decrease in Decreased appetite TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 75 % decrease in Fatigue TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 93 % decrease in Gastrointestinal disorders TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 81 % decrease in General disorders and administration site conditions TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 97 % decrease in Leucopenia TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 74 % decrease in Metabolism and nutrition disorders TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 87 % decrease in Mucosal inflammation TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 97 % decrease in Nausea TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 99 % decrease in Neutropenia TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 89 % decrease in Rash TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 71 % decrease in Severe skin reaction TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 95 % decrease in Stomatitis TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 96 % decrease in Thrombocytopenia TRAE (grade 3-4) but the degree if certainty is unassessable
suggested 76 % decrease in Anaemia AE (grade 3-4) but the degree if certainty is unassessable
suggested 90 % decrease in Blood and lymphatic system disorders AE (grade 3-4) but the degree if certainty is unassessable
suggested 97 % decrease in Febrile neutropenia AE (grade 3-4) but the degree if certainty is unassessable
suggested 67 % decrease in Gastrointestinal disorders AE (grade 3-4) but the degree if certainty is unassessable
suggested 58 % decrease in General disorders and administration site conditions AE (grade 3-4) but the degree if certainty is unassessable
suggested 97 % decrease in Leucopenia AE (grade 3-4) but the degree if certainty is unassessable
suggested 49 % decrease in Metabolism and nutrition disorders AE (grade 3-4) but the degree if certainty is unassessable
suggested 75 % decrease in Mucosal inflammation AE (grade 3-4) but the degree if certainty is unassessable
suggested 97 % decrease in Nausea AE (grade 3-4) but the degree if certainty is unassessable
suggested 60 % decrease in Nervous system disorders AE (grade 3-4) but the degree if certainty is unassessable
suggested 99 % decrease in Neutropenia AE (grade 3-4) but the degree if certainty is unassessable
suggested 89 % decrease in Rash AE (grade 3-4) but the degree if certainty is unassessable
suggested 95 % decrease in Stomatitis AE (grade 3-4) but the degree if certainty is unassessable
suggested 97 % decrease in Thrombocytopenia AE (grade 3-4) but the degree if certainty is unassessable
suggested 88 % decrease in Vomiting AE (grade 3-4) but the degree if certainty is unassessable
delta: difference in rate or median (if available)
An extraction panel is open